Group One Trading’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-8,796
| Closed | -$38.3K | – | 7995 |
|
|
2025
Q3 | $27.7K | Buy |
8,796
+1,403
| +19% | +$3.85K | ﹤0.01% | 6435 |
|
|
2025
Q2 | $16.7K | Buy |
+7,393
| New | +$21.1K | ﹤0.01% | 6392 |
|
|
2024
Q2 | – | Sell |
-6,555
| Closed | -$31.6K | – | 6617 |
|
|
2024
Q1 | $29.8K | Sell |
6,555
-6,160
| -48% | -$27.3K | ﹤0.01% | 5130 |
|
|
2023
Q4 | $52.4K | Buy |
12,715
+2,685
| +27% | +$11.7K | ﹤0.01% | 5023 |
|
|
2023
Q3 | $43.1K | Sell |
10,030
-3,576
| -26% | -$18K | ﹤0.01% | 5241 |
|
|
2023
Q2 | $70.6K | Sell |
13,606
-123,640
| -90% | -$867K | ﹤0.01% | 4960 |
|
|
2023
Q1 | $933K | Buy |
137,246
+87,924
| +178% | +$418K | ﹤0.01% | 2202 |
|
|
2022
Q4 | $122K | Buy |
49,322
+6,861
| +16% | +$17.6K | ﹤0.01% | 4261 |
|
|
2022
Q3 | $140K | Buy |
42,461
+24,247
| +133% | +$116K | ﹤0.01% | 4467 |
|
|
2022
Q2 | $89K | Buy |
18,214
+16,459
| +938% | +$112K | ﹤0.01% | 5084 |
|
|
2022
Q1 | $13K | Buy |
+1,755
| New | +$13.1K | ﹤0.01% | 7031 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$1K | – | 4784 |
|
|
2017
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 4686 |
|
|
2017
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 4617 |
|
|
2017
Q1 | $2K | Hold |
2
| – | – | ﹤0.01% | 4429 |
|
|
2016
Q4 | $2K | Hold |
2
| – | – | ﹤0.01% | 4235 |
|
|
2016
Q3 | $2K | Hold |
2
| – | – | ﹤0.01% | 4353 |
|
|
2016
Q2 | $4K | Buy |
+2
| New | +$4.18K | ﹤0.01% | 4314 |
|
|
2016
Q1 | – | Sell |
-8
| Closed | -$13K | – | 4510 |
|
|
2015
Q4 | $22K | Buy |
8
+2
| +33% | +$8.45K | ﹤0.01% | 3863 |
|
|
2015
Q3 | $27K | Buy |
+6
| New | +$36.1K | ﹤0.01% | 3893 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4651 |
|
|
2015
Q1 | – | Sell |
-7
| Closed | -$34.4K | – | 4707 |
|
|
2014
Q4 | $37K | Buy |
7
+1
| +17% | +$4.89K | ﹤0.01% | 3566 |
|
|
2014
Q3 | $33K | Sell |
6
-21
| -78% | -$146K | ﹤0.01% | 3806 |
|
|
2014
Q2 | $221K | Sell |
27
-2
| -7% | -$24.6K | ﹤0.01% | 2316 |
|
|
2014
Q1 | $745K | Buy |
29
+26
| +867% | +$639K | 0.01% | 1320 |
|
|
2013
Q4 | $51K | Buy |
3
+1
| +50% | +$17.5K | ﹤0.01% | 3594 |
|
|
2013
Q3 | $33K | Sell |
2
-1
| -33% | -$20.7K | ﹤0.01% | 3846 |
|
|
2013
Q2 | $56K | Buy |
+3
| New | +$67.1K | ﹤0.01% | 3331 |
|
Other funds holding ACHV
PBM
VCM
SAM
NCM
Group One Trading's ACHV Position: Q4 2025 in Review
Group One Trading sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 8,796 shares — an estimated $38.3K sold.
Group One Trading first reported a position in ACHV in Q2 2013 and held it in 26 quarters. The position peaked at $933K in Q1 2023. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.
- Group One Trading reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 8,796 Achieve Life Sciences shares in Q4 2025, an estimated $38.3K.
- Group One Trading first reported a position in Achieve Life Sciences in Q2 2013 and held it in 26 quarters.
- Group One Trading's Achieve Life Sciences position peaked at $933K in Q1 2023.
- 77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.